Gait Disorders (Chapter 10) Aspen 2019

Total Page:16

File Type:pdf, Size:1020Kb

Gait Disorders (Chapter 10) Aspen 2019 Hallett: Gait (no videos) Summer 2020 Gait Disorders (Chapter 10) Aspen 2019 1 Extent of the Problem • Major problem in the population, especially in the elderly • Significant cause of disability • Common causes include stroke, peripheral neuropathy, brain or spinal cord trauma, Parkinson’s disease 2 1 Hallett: Gait (no videos) Summer 2020 Capability for Gait • Highly complex motor control problem • Balance – Assume upright position, support, react to perturbations • Locomotion – Initiate steps, steps, adapt steps to circumstances 3 Multiple levels of control • Stepping machinery in the spinal cord • Whole brain gets involved, including cerebral cortex – Walking requires some attention – Why else would it be difficult to walk and chew gum at the same time? – “Stops walking when talking” test can bring out abnormalities • Lundin-Olsson et al. 1997 4 2 Hallett: Gait (no videos) Summer 2020 CLR Nutt, Bloem, Giladi, Hallett, Horak, Nieuwboer Lancet Neurology 2011 5 Gait Cycle 6 3 Hallett: Gait (no videos) Summer 2020 Elemental Descriptions of Gait • Stride length • Cadence • Deviation from direction of travel • Base (standing and walking) • Angular movement of joints • Variability • Rigidity/fluidity • Initiation and maintenance of walking • Adaptability » Modified from Nutt 2001 7 Elemental Disorders of Gait • Weakness: myopathy, neuropathy • Dysmetric: ataxia, chorea • Stiff/rigid: spasticity, parkinsonism, dystonia • Veering: vestibular disorders • Freezing: parkinsonism,frontal gait disorder – Motor block, lack of movement – Rapid side to side shifing of weight (slipping clutch syndrome) • Marché à petit pas: parkinsonism,frontal gait disorder • Festination: parkinsonism » Modified from Nutt 2001 8 4 Hallett: Gait (no videos) Summer 2020 Anatomical/Physiological Classification of Gait • Lowest-level disorders – Muscle, nerve, root, elemental sensory deficits (vision, neuropathy) • Middle-level disorders – Corticospinal tract, cerebellum, basal ganglia • Highest-level disorders – Cerebral hemispheres, functional (psychogenic) » Nutt, Marsden and Thompson 1993 9 Lowest-level Gait Disorders • Myopathic • Peripheral neuropathic • Sensory ataxic • Vestibular • Visual deficits 10 5 Hallett: Gait (no videos) Summer 2020 Gait patterns with Weakness • Steppage: foot drop with compensatory increased flexion of hip and knee • Waddle: weakness of hip abductors leading to dropping of the opposite side of the pelvis 11 Middle-level Gait Disorders • Hemiplegia and paraplegia (spasticity) • Ataxia • Parkinsonian • Dystonic • Choreic • Myoclonic 13 6 Hallett: Gait (no videos) Summer 2020 Hemiplegia and paraplegia (spasticity) • Hemiparetic: Stiff extended leg that circumducts during swing with scraping of the toe • Paraparetic: Stiffness of both legs with scissoring 14 Stiff-legged Gait • Stiff-person syndrome, reduction of range of motion of all joints including spine 17 7 Hallett: Gait (no videos) Summer 2020 Parkinsonian gait • First manifestation is that gait slows, more due to step length than cadence • Lack of arm swing, tremor of hands • Short, shuffling, slow steps possibly with festination • En bloc turns • Narrow base • Poor balance • Freezing that may improve with external cues 19 Lancet Neurol 2011; 10: 734–44 22 8 Hallett: Gait (no videos) Summer 2020 23 “We propose that this new gait pattern, which we term “gunslinger’s gait,” may result from a behavioural adaptation, possibly triggered by KGB or other forms of weapons training where trainees are taught to keep their right hand close to the chest while walking, allowing them to quickly draw a gun when faced with a foe.” 25 9 Hallett: Gait (no videos) Summer 2020 Dystonic gait • Action dystonia of the legs with walking, often inversion of the foot • Can affect the trunk and arms • Walking backwards might be better than forwards 26 30 10 Hallett: Gait (no videos) Summer 2020 Note also manganese toxicity itself and methcathinone (ephedrine) toxicity 31 33 11 Hallett: Gait (no videos) Summer 2020 Hobby Horse Gait of DYT4 35 Ataxic gait • Poor balance • Irregular stepping is principal feature • Slow with reduced stride length • Normal and then widened base • Note that similar patterns, but mild, are seen in essential tremor 37 12 Hallett: Gait (no videos) Summer 2020 Choreic gait • Dancing gait • Uncoordinated stepping 39 Myoclonic gait • Bouncy gait 41 13 Hallett: Gait (no videos) Summer 2020 Orthostatic Myoclonus Seen mainly in the setting of other gait disorders, such as frontal gait disorder Treatable, at least to some extent, with clonazepam Glass, G. A. et al. Neurology 2007;68:1826-1830 43 Gait findings similar to those in ataxia 46 14 Hallett: Gait (no videos) Summer 2020 Highest-level Gait Disorders • Frontal gait disorder • Cautious gait • Functional (Psychogenic) gait • Cognitive disorders 47 Frontal Gait Disorder • Short steps, shuffling, hesitation on turns with some disequilibrium and some initiation failure (marché à petit pas) • Can involve only the lower part of the body, called “lower-half parkinsonism” 48 15 Hallett: Gait (no videos) Summer 2020 Frontal Gait Disorder versus Parkinson Gait Frontal Gait Disorder Parkinson Gait • Wide-based • Narrow base • Normal arm swing • Reduced arm swing • No improvement with sensory • Improvement with sensory cues cues • Minimal response to L-DOPA • Good response to L-DOPA • Lack of festination • Possible festination From Alberto Espay 49 “Frontal Gait Disorders” • Etiologies include subcortical arteriosclerotic encephalopathy (Binswanger’s disease), multi- infarct state, normal pressure hydrocephalus, Frontotemporal dementia, corticobasal degeneration, PSP (primary progressive freezing gait) 50 16 Hallett: Gait (no videos) Summer 2020 55 Normal pressure hydrocephalus Atrophy 56 17 Hallett: Gait (no videos) Summer 2020 35 subjects with clinically confirmed iNPH and 45 matched healthy controls Best measures were simple linear measurements of vertical or horizontal frontal horn diameters 57 Underlying etiology might be PSP, AD, DLB, etc. 59 18 Hallett: Gait (no videos) Summer 2020 Neurosurgery on-line Of 328 total patients, 45% had an alternative diagnosis. 11% of all patients improved with treatment of an alternative diagnosis. Of 87 patients with treatable conditions, the highest frequency of pathologies included sleep disorders, and cervical stenosis, followed by Parkinson disease. Only 26% underwent shunting and those had a good response 62 “Fifty years is too long for our profession to continue recommending surgery for a disease whose very existence has never been subjected to a critical test.” “…I think that equipoise demands a moratorium on all shunting procedures for “iNPH.” 63 19 Hallett: Gait (no videos) Summer 2020 Cautious Gait • Widened base with slow, short steps • Turns en bloc • Arms tensed looking for support, and gait improves significantly with support • Anxiety • No freezing or shuffling • “like walking on ice” 64 Functional gait • AKA astasia-abasia, acrobatic gait • Unusual patterns of stance and gait, often inconsistent, and often demonstrating excellent balance • Common are: lurching without falls, sudden knee buckling, extreme slow motion • Positive psychiatric features 66 20 Hallett: Gait (no videos) Summer 2020 VIDEOS! 67 Cognitive Disorders • While gait is somewhat automatic, it does require some cognitive control • Gait may well deteriorate under dual task conditions 71 21 Hallett: Gait (no videos) Summer 2020 72 Multifactorial Etiology • Disorders of gait are often multifactorial – Particularly in the elderly! 73 22 Hallett: Gait (no videos) Summer 2020 Therapeutic Considerations • Etiologic considerations come first! – Treatable neuropathies – Normal pressure hydrocephalus? – Parkinson disease (in addition to regular treatment) • Physical therapy • Dance therapy • Therapy for Gait freezing 74 Physical Therapy Rutz & Benninger 2020 PM&R •All Category A recommendations –Cueing, auditory and visual – Treadmill walking – Aquatic obstacle training – Supervised slackline training 75 23 Hallett: Gait (no videos) Summer 2020 76 FOG Treatment Gao et al. 2020 Transl Neurodegen • Compensation strategies • Pharmacological – Dopaminergic drugs – Promising: istradefylline, rasagiline • Non-pharmacological – Invasive and non-invasive brain stimulation – Spinal cord stimulation – Vagus nerve stimulation – Physical therapy 77 24 Hallett: Gait (no videos) Summer 2020 Using external cues Using internal cues Changing balance requirements Altering the mental state Motor imagery or action observation New walking pattern 78 Small number of cases and possible biases recognized Maybe a benefit short term, but lost in long term (>12 months) 80 25 Hallett: Gait (no videos) Summer 2020 PPN DBS Snijders et al. Ann Neurol 2016;80:644 81 Page 278 82 26 Hallett: Gait (no videos) Summer 2020 p. 5 patients with PD had significant improvement at 6 months, including FOG 83 Movement Disorders 2020 on‐line 6 patients, all failed to have any benefit 84 27 Hallett: Gait (no videos) Summer 2020 Conclusion • Many different types of gait disorders – Leading to significant disability – Increasing possibility for falls • Therapies are often insufficient • There is much more work to do in this area 85 Questions? 86 28.
Recommended publications
  • Multiplex Families with Multiple System Atrophy
    ORIGINAL CONTRIBUTION Multiplex Families With Multiple System Atrophy Kenju Hara, MD, PhD; Yoshio Momose, MD, PhD; Susumu Tokiguchi, MD, PhD; Mitsuteru Shimohata, MD, PhD; Kenshi Terajima, MD, PhD; Osamu Onodera, MD, PhD; Akiyoshi Kakita, MD, PhD; Mitsunori Yamada, MD, PhD; Hitoshi Takahashi, MD, PhD; Motoyuki Hirasawa, MD, PhD; Yoshikuni Mizuno, MD, PhD; Katsuhisa Ogata, MD, PhD; Jun Goto, MD, PhD; Ichiro Kanazawa, MD, PhD; Masatoyo Nishizawa, MD, PhD; Shoji Tsuji, MD, PhD Background: Multiple system atrophy (MSA) has Results: Consanguineous marriage was observed in 1 been considered a sporadic disease, without patterns of of 4 families. Among 8 patients, 1 had definite MSA, 5 inheritance. had probable MSA, and 2 had possible MSA. The most frequent phenotype was MSA with predominant parkin- Objective: To describe the clinical features of 4 multi- sonism, observed in 5 patients. Six patients showed pon- plex families with MSA, including clinical genetic tine atrophy with cross sign or slitlike signal change at aspects. the posterolateral putaminal margin or both on brain mag- netic resonance imaging. Possibilities of hereditary atax- Design: Clinical and genetic study. ias, including SCA1 (ataxin 1, ATXN1), SCA2 (ATXN2), Machado-Joseph disease/SCA3 (ATXN1), SCA6 (ATXN1), Setting: Four departments of neurology in Japan. SCA7 (ATXN7), SCA12 (protein phosphatase 2, regula- tory subunit B, ␤ isoform; PP2R2B), SCA17 (TATA box Patients: Eight patients in 4 families with parkinson- binding protein, TBP) and DRPLA (atrophin 1; ATN1), ism, cerebellar ataxia, and autonomic failure with age at ␣ onset ranging from 58 to 72 years. Two siblings in each were excluded, and no mutations in the -synuclein gene family were affected with these conditions.
    [Show full text]
  • A Review on Parkinson's Disease Treatment
    Lee et al. Neuroimmunol Neuroinflammation 2021;8:[Online First] Neuroimmunology DOI: 10.20517/2347-8659.2020.58 and Neuroinflammation Review Open Access A review on Parkinson’s disease treatment Tori K. Lee, Eva L. Yankee Department of Biology, Pacific Union College, Angwin, CA 94508, USA. Correspondence to: Tori K. Lee, Department of Biology, Pacific Union College, 1 Angwin Ave, Angwin, CA 94508, USA. E-mail: [email protected] How to cite this article: Lee TK, Yankee EL. A review on Parkinson’s disease treatment. Neuroimmunol Neuroinflammation 2021;8:[Online First]. http://dx.doi.org/10.20517/2347-8659.2020.58 Received: 1 Oct 2020 First Decision: 1 Dec 2020 Revised: 15 Dec 2020 Accepted: 24 Dec 2020 Available online: 25 Jan 2021 Academic Editors: Athanassios P. Kyritsis, Backil Sung Copy Editor: Monica Wang Production Editor: Jing Yu Abstract Parkinson’s disease (PD) is a neurodegenerative illness and has a common onset between the ages of 55 and 65 years. There is progressive development of both motor and non-motor symptoms, greatly affecting one’s overall quality of life. While there is no cure, various treatments have been developed to help manage the symptoms of PD. Management of PD is a growing field and targets new treatment methods, as well as improvements to old ones. Pharmacological, surgical, and therapeutic treatments have allowed physicians to treat not only the main motor symptoms of PD, but target patient-specific problems as they arise. This review discusses both the established and new possibilities for PD treatment that can provide patient-specific care and mitigate side effects for common treatments.
    [Show full text]
  • Efficacy of Rhythmic Auditory Stimulation on Ataxia and Functional Dependence Post- Cerebellar Stroke" (2020)
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale School of Medicine Physician Associate Program Theses School of Medicine 5-22-2020 Efficacy of Rhythmicudit A ory Stimulation on Ataxia and Functional Dependence Post-Cerebellar Stroke Kaitlin Fitzgerald Yale Physician Associate Program, [email protected] Follow this and additional works at: https://elischolar.library.yale.edu/ysmpa_theses Recommended Citation Fitzgerald, Kaitlin, "Efficacy of Rhythmic Auditory Stimulation on Ataxia and Functional Dependence Post- Cerebellar Stroke" (2020). Yale School of Medicine Physician Associate Program Theses. 13. https://elischolar.library.yale.edu/ysmpa_theses/13 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale School of Medicine Physician Associate Program Theses by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. EFFICACY OF RHYTHMIC AUDITORY STIMULATION ON ATAXIA AND FUNCTIONAL DEPENDENCE POST-CEREBELLAR STROKE A Thesis Presented to The Faculty of the School of Medicine Yale University In Candidacy for the degree of Master of Medical Science May 2020 Kaitlin Fitzgerald, PA-SII Dr. Diana Richardson, MD Class of 2020 Assistant Clinical Professor Yale Physician Associate Program. Yale School of Medicine, Neurology i Table of Contents ABSTRACT
    [Show full text]
  • Neurologic Outcomes in Friedreich Ataxia: Study of a Single-Site Cohort E415
    Volume 6, Number 3, June 2020 Neurology.org/NG A peer-reviewed clinical and translational neurology open access journal ARTICLE Neurologic outcomes in Friedreich ataxia: Study of a single-site cohort e415 ARTICLE Prevalence of RFC1-mediated spinocerebellar ataxia in a North American ataxia cohort e440 ARTICLE Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy e428 ARTICLE Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy revisited: Genotype-phenotype correlations of all published cases e434 Academy Officers Neurology® is a registered trademark of the American Academy of Neurology (registration valid in the United States). James C. Stevens, MD, FAAN, President Neurology® Genetics (eISSN 2376-7839) is an open access journal published Orly Avitzur, MD, MBA, FAAN, President Elect online for the American Academy of Neurology, 201 Chicago Avenue, Ann H. Tilton, MD, FAAN, Vice President Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at 14700 Citicorp Drive, Bldg. 3, Hagerstown, MD 21742. Business offices are located at Two Carlayne E. Jackson, MD, FAAN, Secretary Commerce Square, 2001 Market Street, Philadelphia, PA 19103. Production offices are located at 351 West Camden Street, Baltimore, MD 21201-2436. Janis M. Miyasaki, MD, MEd, FRCPC, FAAN, Treasurer © 2020 American Academy of Neurology. Ralph L. Sacco, MD, MS, FAAN, Past President Neurology® Genetics is an official journal of the American Academy of Neurology. Journal website: Neurology.org/ng, AAN website: AAN.com CEO, American Academy of Neurology Copyright and Permission Information: Please go to the journal website (www.neurology.org/ng) and click the Permissions tab for the relevant Mary E.
    [Show full text]
  • Movement Disorders in the Elderly
    MOVEMENT DISORDERS IN THE ELDERLY Eugene C. Lai, M.D., Ph.D. Michael E. DeBakey VA Medical Center Baylor College of Medicine Houston, Texas MOVEMENT DISORDERS Neurologic dysfunctions in which there is either a paucity of voluntary and automatic movements (HYPOKINESIA) or an excess of movement (HYPERKINESIA) or uncontrolled movements (DYSKINESIA) typically unassociated with weakness or spasticity HYPOKINESIAS • Parkinson‟s disease • Secondary Parkinsonism • Parkinson‟s plus syndromes HYPERKINESIAS • Akathisia • Hemifacial spasm • Athetosis • Myoclonus • Ballism • Restless leg syndrome • Chorea • Tics • Dystonia • Tremor COMMON MOVEMENT DISORDERS IN THE ELDERLY • Parkinsonism • Tremor • Gait disorder • Restless leg syndrome • Drug-induced syndrome PARKINSONISM • Parkinson‟s disease • Secondary parkinsonism • Drug-induced parkinsonism • Vascular parkinsonism • Parkinson‟s plus syndromes • Multiple system atrophy • Progressive supranuclear palsy PARKINSON’S DISEASE PARKINSON’S DISEASE Classical Clinical Features • Resting Tremor • Cogwheel Rigidity • Bradykinesia • Postural Instability PARKINSON’S DISEASE Associated Clinical Features • Micrographia • Hypophonia • Hypomimia • Shuffling gait / festination • Drooling • Dysphagia NON-MOTOR COMPLICATIONS IN PARKINSON’S DISEASE • Sleep disturbances • Autonomic dysfunctions • Sensory phenomena • Neuropsychiatric manifestations • Cognitive impairment PARKINSON’S DISEASE General Considerations • The second most common progressive neurodegenerative disorder • The most common neurodegenerative movement
    [Show full text]
  • Pseudoparkinsonism: a Review of a Common Nonparkinsonian Hypokinetic Movement Disorder
    Vol.2, No.4, 108-112 (2013) Advances in Parkinson’s Disease http://dx.doi.org/10.4236/apd.2013.24020 Pseudoparkinsonism: A review of a common nonparkinsonian hypokinetic movement disorder Roger Kurlan*, Marcie L. Rabin Atlantic Neuroscience Institute, Overlook Medical Center, Summit, USA; *Corresponding Author: [email protected] Received 16 September 2013; revised 16 October 2013; accepted 24 October 2013 Copyright © 2013 Roger Kurlan, Marcie L. Rabin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT [2-4]. Over time, clinicians learned that a variety of entities This article reviews the syndrome pseudopark- besides neuroleptic drugs can similarly cause a clinical insonism, a movement disorder described in the picture resembling that of PD. The notion that a parkin- literature that resembles parkinsonism but dif- sonian syndrome could be caused by cerebrovascular fers qualitatively. Patients with this disorder disease became popularized in the 1980’s and 1990’s. have apraxic slowness, paratonic rigidity, frontal Some publications referred to the condition as “vascular gait disorder and elements of akinesia that, pseudoparkinsonism” [5,6], similar to the term used for taken together, may be mistaken for true park- neuroleptic drugs. Other articles, in contrast, used the insonism. Pseudoparkinsonism appears to be term “vascular parkinsonism” to describe features with a common and is most often due to Alzheimer’s vascular etiology that are reminiscent of, but distinct disease or vascular dementia. It seems that pa- from, those found in PD.
    [Show full text]
  • Tremor, Abnormal Movement and Imbalance Differential
    Types of involuntary movements Tremor Dystonia Chorea Myoclonus Tics Tremor Rhythmic shaking of muscles that produces an oscillating movement Parkinsonian tremor Rest tremor > posture > kinetic Re-emergent tremor with posture Usually asymmetric Pronation-supination tremor Distal joints involved primarily Often posturing of the limb Parkinsonian tremor Other parkinsonian features Bradykinesia Rigidity Postural instability Many, many other motor and non- motor features Bradykinesia Rigidity Essential tremor Kinetic > postural > rest Rest in 20%, late feature, only in arms Intentional 50% Bringing spoon to mouth is challenging!! Mildly asymmetric Gait ataxia – typically mild Starts in the arms but can progress to neck, voice and jaw over time Jaw tremor occurs with action, not rest Neck tremor should resolve when patient is lying flat Essential tremor Many other tremor types Physiologic tremor Like ET but faster rate and lower amplitude Drug-induced tremor – Lithium, depakote, stimulants, prednisone, beta agonists, amiodarone Anti-emetics (phenergan, prochlorperazine), anti-psychotics (except clozapine and Nuplazid) Many other tremor types Primary writing tremor only occurs with writing Orthostatic tremor leg tremor with standing, improves with walking and sitting, causes imbalance Many other tremor types Cerebellar tremor slowed action/intention tremor Holmes tremor mid-brain lesion, unilateral Dystonia Dystonia Muscle contractions that cause sustained or intermittent torsion of a body part in a repetitive
    [Show full text]
  • Management of Balance and Gait in Older Individuals with Parkinson's Disease Ryan P
    Washington University School of Medicine Digital Commons@Becker Physical Therapy Faculty Publications Program in Physical Therapy 2011 Management of balance and gait in older individuals with Parkinson's disease Ryan P. Duncan Washington University School of Medicine in St. Louis Abigail L. Leddy Washington University School of Medicine in St. Louis Gammon M. Earhart Washington University School of Medicine in St. Louis Follow this and additional works at: http://digitalcommons.wustl.edu/pt_facpubs Recommended Citation Duncan, Ryan P.; Leddy, Abigail L.; and Earhart, Gammon M., "Management of balance and gait in older individuals with Parkinson's disease" (2011). Physical Therapy Faculty Publications. Paper 32. http://digitalcommons.wustl.edu/pt_facpubs/32 This Article is brought to you for free and open access by the Program in Physical Therapy at Digital Commons@Becker. It has been accepted for inclusion in Physical Therapy Faculty Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. 1 Management of Balance and Gait in Older Individuals with Parkinson Disease 2 Duncan R.P.1, Leddy A.L.1, Earhart G.M.1,2,3 3 1Washington University in St. Louis School of Medicine, Program in Physical Therapy 4 2Washington University in St. Louis School of Medicine, Department of Anatomy & Neurobiology 5 3Washington University in St. Louis School of Medicine, Department of Neurology 6 7 Corresponding Author: 8 Gammon M. Earhart, PhD, PT 9 Washington University School of Medicine 10 Program in Physical Therapy 11 Campus Box 8502 12 4444 Forest Park Blvd. 13 St. Louis, MO 63108 14 314-286-1425 15 Email: [email protected] 16 17 Summary 18 Difficulties with walking and balance are common among people with Parkinson disease 19 (PD).
    [Show full text]
  • GAIT DISORDERS, FALLS, IMMOBILITY Mov7 (1)
    GAIT DISORDERS, FALLS, IMMOBILITY Mov7 (1) Gait Disorders, Falls, Immobility Last updated: April 17, 2019 GAIT DISORDERS ..................................................................................................................................... 1 CLINICAL FEATURES .............................................................................................................................. 1 CLINICO-ANATOMICAL SYNDROMES .............................................................................................. 1 CLINICO-PHYSIOLOGICAL SYNDROMES ......................................................................................... 1 Dyssynergy Syndromes .................................................................................................................... 1 Frontal gait ............................................................................................................................ 2 Sensory Gait Syndromes .................................................................................................................. 2 Sensory ataxia ........................................................................................................................ 2 Vestibular ataxia .................................................................................................................... 2 Visual ataxia .......................................................................................................................... 2 Multisensory disequilibrium .................................................................................................
    [Show full text]
  • The Pedunculopontine Nucleus Area: Critical Evaluation of Interspecies Differences Relevant
    doi:10.1093/brain/awq322 Brain 2011: 134; 11–23 | 11 BRAIN A JOURNAL OF NEUROLOGY REVIEW ARTICLE The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation Downloaded from https://academic.oup.com/brain/article/134/1/11/293572 by guest on 23 September 2021 Mesbah Alam, Kerstin Schwabe and Joachim K. Krauss Department of Neurosurgery, Medical University of Hannover, Hannover 30625, Germany Correspondence to: Prof. Dr. med. Joachim K. Krauss, Department of Neurosurgery, Medical University of Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany E-mail: [email protected] Recently, the pedunculopontine nucleus has been highlighted as a target for deep brain stimulation for the treatment of freezing of postural instability and gait disorders in Parkinson’s disease and progressive supranuclear palsy. There is great controversy, however, as to the exact location of the optimal site for stimulation. In this review, we give an overview of anatomy and connectivity of the pedunculopontine nucleus area in rats, cats, non-human primates and humans. Additionally, we report on the behavioural changes after chemical or electrical manipulation of the pedunculopontine nucleus. We discuss the relation to adjacent regions of the pedunculopontine nucleus, such as the cuneiform nucleus and the subcuneiform nucleus, which together with the pedunculopontine nucleus are the main areas of the mesencephalic locomotor region and play a major role in the initiation of gait. This information is discussed with respect to the experimental designs used for research purposes directed to a better understanding of the circuitry pathway of the pedunculopontine nucleus in association with basal ganglia pathology, and with respect to deep brain stimulation of the pedunculopontine nucleus area in humans.
    [Show full text]
  • Detection of Gait Abnormalities Caused by Neurological Disorders
    Detection of Gait Abnormalities caused by Neurological Disorders Daksh Goyal Koteswar Rao Jerripothula Ankush Mittal Department of Civil Engineering Department of Computer Science and Engineering Raman Classes NIT Karnataka Indraprastha Institute of Information Technology Delhi Roorkee, India Surathkal, India New Delhi, India [email protected] [email protected] [email protected] Abstract—In this paper, we leverage gait to potentially detect some of the important neurological disorders, namely Parkinson’s disease, Diplegia, Hemiplegia, and Huntington’s Chorea. Persons with these neurological disorders often have a very abnormal gait, which motivates us to target gait for their potential detection. Parkinsonian Gait Diplegic Gait Some of the abnormalities involve the circumduction of legs, forward-bending, involuntary movements, etc. To detect such abnormalities in gait, we develop gait features from the key-points of the human pose, namely shoulders, elbows, hips, knees, ankles, Hemiplegic Gait Choreiform Gait etc. To evaluate the effectiveness of our gait features in detecting Fig. 1. Gait Abnormalities the abnormalities related to these diseases, we build a synthetic video dataset of persons mimicking the gait of persons with such disorders, considering the difficulty in finding a sufficient number of people with these disorders. We name it NeuroSynGait video disorders. Even doctors consider such visible symptoms as dataset. Experiments demonstrated that our gait features were a basis for their diagnosis to identify the root cause of the indeed successful in detecting these abnormalities. problem. This research attempts to expedite the diagnosis Index Terms—gait, neurological, disorders, Parkinson’s, Diple- gia, Hemiplegia, Choreiform process by automating this step with computer vision and machine learning algorithms.
    [Show full text]
  • Inhaling Xenon Ameliorates L -Dopa-Induced Dyskinesia In
    Inhaling xenon ameliorates l -dopa-induced dyskinesia in experimental parkinsonism Jérôme Baufreton, Tomislav Milekovic, Qin Li, Steve Mcguire, Eduardo Martin Moraud, Gregory Porras, Shiqi Sun, Wai Kin D. Ko, Marine Chazalon, Stephanie Morin, et al. To cite this version: Jérôme Baufreton, Tomislav Milekovic, Qin Li, Steve Mcguire, Eduardo Martin Moraud, et al.. Inhal- ing xenon ameliorates l -dopa-induced dyskinesia in experimental parkinsonism. Movement Disorders, Wiley, 2018, 33 (10), pp.1632-1642. 10.1002/mds.27404. hal-02275286 HAL Id: hal-02275286 https://hal.archives-ouvertes.fr/hal-02275286 Submitted on 26 Jan 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. RESEARCH ARTICLE Inhaling Xenon Ameliorates L-Dopa-Induced Dyskinesia in Experimental Parkinsonism Jer ome^ Baufreton, PhD,1,2 Tomislav Milekovic, PhD,3 Qin Li, PhD,4 Steve McGuire, MS,4 Eduardo Martin Moraud, PhD,3 Gregory Porras, PhD,4 Shiqi Sun, PhD,3 Wai Kin D. Ko, PhD,4 Marine Chazalon, PhD,1,2 Stephanie Morin, Bsc,1,2 Elisabeth Normand, PhD,5,6 Geraldine Farjot, PhD,7 Aude Milet,
    [Show full text]